Logo image of SNDX

SYNDAX PHARMACEUTICALS INC (SNDX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:SNDX - US87164F1057 - Common Stock

20.47 USD
-0.25 (-1.21%)
Last: 1/13/2026, 8:00:02 PM
20.7964 USD
+0.33 (+1.59%)
After Hours: 1/13/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SNDX revenue by date.SNDX revenue by date.

-100.00%
23.68M170.53M
620.14%
367.36M
115.42%
563.64M
53.43%
754.89M
33.93%
967.7M
28.19%
1.168B
20.70%
1.461B
25.09%
1.668B
14.17%
1.282B
-23.14%
EBITDA
YoY % growth
SNDX ebitda by date.SNDX ebitda by date.
-151.77M
-678.39%
-229.942M
-51.51%
-339.664M
-47.72%
-268.325M
21.00%
-175.306M
34.67%
-32.372M
81.53%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
SNDX ebit by date.SNDX ebit by date.
-151.8M
-679.39%
-229.954M
-51.48%
-339.672M
-47.71%
-269.339M
20.71%
-145.647M
45.92%
-30.266M
79.22%
154.81M
611.49%
308.16M
99.06%
463.25M
50.33%
796.55M
71.95%
992.33M
24.58%
564.26M
-43.14%
Operating Margin
SNDX operating margin by date.SNDX operating margin by date.
N/AN/A-1,434.43%-157.94%-39.65%-5.37%20.51%31.84%39.66%54.52%59.49%44.01%
EPS
YoY % growth
SNDX eps by date.SNDX eps by date.
-2.45
-669.77%
-2.96
-20.82%
-3.73
-26.01%
-3.18
14.66%
-1.73
45.68%
-0.19
89.24%
1.34
822.35%
2.44
81.79%
3.54
44.66%
5.41
53.11%
6.69
23.68%
4.78
-28.54%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.60
45.33%
-0.61
37.81%
-0.50
40.09%
-0.37
47.32%
-0.25
58.62%
Revenue
Q2Q % growth
65.383M
751.34%
68.504M
241.80%
83.422M
119.77%
96.249M
109.83%
115.64M
76.87%
EBITDA
Q2Q % growth
-49.032M
48.92%
-51.44M
38.40%
-47.836M
31.03%
-39.693M
30.88%
N/A
EBIT
Q2Q % growth
-51.971M
45.86%
-42.778M
48.77%
-34.146M
50.76%
-24.094M
58.04%
-10.863M
79.10%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.70
28.57%
-0.730.034.24%
Q2 2025
Q2Q % growth
-0.83
-3.75%
-1.040.2119.92%
Q1 2025
Q2Q % growth
-0.98
-15.29%
-1.360.3827.80%
Q4 2024
Q2Q % growth
-1.10
-10.00%
-0.23-0.87-370.62%
Q3 2024
Q2Q % growth
-0.98
-34.25%
-1.140.1613.67%
Q2 2024
Q2Q % growth
-0.80
-25.00%
-0.930.1314.20%
Q1 2024
Q2Q % growth
-0.85
-44.07%
-1.000.1514.84%
Q4 2023
Q2Q % growth
-1.00
-61.29%
-1.010.011.39%
Q3 2023
Q2Q % growth
-0.73
-25.86%
-0.810.0810.03%
Q2 2023
Q2Q % growth
-0.64
-3.23%
-0.750.1114.31%
Q1 2023
Q2Q % growth
-0.59
6.35%
-0.610.022.90%
Q4 2022
Q2Q % growth
-0.62
-134.25%
-0.660.046.31%
Q3 2022
Q2Q % growth
-0.58
-45.00%
-0.650.0710.45%
Q2 2022
Q2Q % growth
-0.62
-40.91%
-0.650.034.53%
Q1 2022
Q2Q % growth
-0.63
-16.67%
-0.650.022.73%
Q4 2021
Q2Q % growth
1.81
511.36%
0.281.53537.56%
Q3 2021
Q2Q % growth
-0.40
13.04%
-0.24-0.16-69.27%
Q2 2021
Q2Q % growth
-0.44
-4.76%
-0.730.2939.67%
Q1 2021
Q2Q % growth
-0.54
3.57%
-0.660.1218.34%
Q4 2020
Q2Q % growth
-0.44 -0.500.0611.33%
Q3 2020
Q2Q % growth
-0.46 -0.45-0.01-3.12%
Q2 2020
Q2Q % growth
-0.42 -0.450.037.64%
Q1 2020
Q2Q % growth
-0.56 -0.52-0.04-6.99%
SNDX Yearly EPS VS EstimatesSNDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
45.871M
266.97%
48.936M-3.065M-6.26%
Q2 2025
Q2Q % growth
37.958M
984.51%
27.361M10.597M38.73%
Q1 2025
Q2Q % growth
20.042M 14.722M5.32M36.14%
Q4 2024
Q2Q % growth
7.68M 87.63M-79.95M-91.24%
Q3 2024
Q2Q % growth
12.5M 11.423M1.077M9.43%
Q1 2023
Q2Q % growth
437.141K-437.141K-100.00%
Q4 2022
Q2Q % growth

-100.00%
382.5K-382.5K-100.00%
Q3 2022
Q2Q % growth

-100.00%
765K-765K-100.00%
Q2 2022
Q2Q % growth

-100.00%
1.403M-1.403M-100.00%
Q1 2022
Q2Q % growth

-100.00%
2.173M-2.173M-100.00%
Q4 2021
Q2Q % growth
126.6M
31,550.00%
59.854M66.746M111.51%
Q3 2021
Q2Q % growth
12.4M
3,000.00%
29.937M-17.537M-58.58%
Q2 2021
Q2Q % growth
400K 183.6K216.4K117.86%
Q1 2021
Q2Q % growth
400K 229.5K170.5K74.29%
Q4 2020
Q2Q % growth
400K 204K196K96.08%
Q3 2020
Q2Q % growth
400K 306K94K30.72%
Q2 2020
Q2Q % growth
400K 408K-8K-1.96%
Q1 2020
Q2Q % growth
400K 860.033K-460.033K-53.49%
SNDX Yearly Revenue VS EstimatesSNDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 3.62% 0% 0.57%
Revenue0% 1.09% 0% -2.84%